{
  "question_stem": {
    "en": "Certain patients with non-small cell lung cancer develop constitutive tumor kinase activity due to the production of echinoderm microtubule-associated protein-like 4 - anaplastic lymphoma kinase (EML4-ALK), a fusion protein that contributes to carcinogenesis. This is most similar to the molecular pathophysiology of which of the following disorders?",
    "zh": "某些非小细胞肺癌患者由于产生棘皮动物微管相关蛋白样4-间变性淋巴瘤激酶（EML4-ALK）而出现持续性肿瘤激酶活性，这是一种有助于癌变的融合蛋白。这与以下哪种疾病的分子病理生理学最相似？"
  },
  "question": {
    "en": "This is most similar to the molecular pathophysiology of which of the following disorders?",
    "zh": "这与以下哪种疾病的分子病理生理学最相似？"
  },
  "options": {
    "A": {
      "en": "Burkitt lymphoma",
      "zh": "伯基特淋巴瘤"
    },
    "B": {
      "en": "Chronic myelogenous leukemia",
      "zh": "慢性髓细胞性白血病"
    },
    "C": {
      "en": "Follicular lymphoma",
      "zh": "滤泡性淋巴瘤"
    },
    "D": {
      "en": "Li-Fraumeni syndrome",
      "zh": "Li-Fraumeni综合征"
    },
    "E": {
      "en": "Mantle cell lymphoma",
      "zh": "套细胞淋巴瘤"
    }
  },
  "correct_answer": "B",
  "explanation": {
    "en": "Approximately four percent of patients with non-small cell lung carcinoma (NSCLC) have an inversion of the short arm of chromosome 2 that creates a fusion gene between EML4 (echinoderm microtubule-associated protein-like 4) and ALK (anaplastic lymphoma kinase). This results in a constitutively active tyrosine kinase that causes malignancy. Interestingly, patients who harbor this gene fusion are usually young non-smokers, often with adenocarcinoma, who lack mutations in either the epidermal growth factor receptor gene or the K-ras gene. The kinase activity of this fusion protein is a target of the protein kinase inhibitor, crizotinib.\n\nThe pathophysiology of EML4-ALK NSCLC is most similar to the pathophysiology of chronic myelogenous leukemia (CML). In CML, the classic and most common cause is a translocation between chromosomes 9 and 22. The ABL proto-oncogene is transported from chromosome 9 to chromosome 22 where it is placed adjacent to the BCR gene. The resulting oncogene, BCR-ABL, codes for a fusion protein with constitutive tyrosine kinase activity. This protein stimulates the proliferation of granulocytic precursors and leads to the development of CML. The kinase activity of this fusion protein is a target of the protein kinase inhibitor, imatinib. {{exhibit_1}}\n\n(Choice A) Burkitt lymphoma is characterized by a translocation of the c-myc oncogene on the long arm of chromosome 8 to the Ig heavy chain region on chromosome 14. This causes constitutive overproduction of c-myc, a nuclear phosphoprotein that functions as a transcription activator.\n\n(Choice C) Patients with follicular lymphoma have a t(14;18) translocation that causes overexpression of the antiapoptotic BCL2 gene product.\n\n(Choice D) Li-Fraumeni syndrome is an autosomal dominant predisposition to a variety of cancers, particularly sarcomas and tumors of the breast, brain, and adrenal cortex. This syndrome is associated with a mutation of the tumor suppressor gene, p53.\n\n(Choice E) Translocation between the cyclin D1 locus on chromosome 11 and the immunoglobulin heavy chain locus on chromosome 14 is characteristic of mantle cell lymphoma. This abnormality results in increased production of cyclin D1, a promoter of the G1 to S-phase transition during the cell cycle.",
    "zh": "大约4%的非小细胞肺癌（NSCLC）患者的2号染色体短臂发生倒位，从而在EML4（棘皮动物微管相关蛋白样4）和ALK（间变性淋巴瘤激酶）之间产生融合基因。这导致组成型活化的酪氨酸激酶，引起恶性肿瘤。有趣的是，携带这种基因融合的患者通常是年轻的非吸烟者，通常患有腺癌，并且缺乏表皮生长因子受体基因或K-ras基因的突变。这种融合蛋白的激酶活性是蛋白激酶抑制剂克唑替尼的靶标。\n\nEML4-ALK NSCLC的病理生理学与慢性髓细胞性白血病（CML）的病理生理学最相似。在CML中，最常见的原因是9号染色体和22号染色体之间的易位。ABL原癌基因从9号染色体转移到22号染色体，在那里它与BCR基因相邻。由此产生的癌基因BCR-ABL编码具有组成型酪氨酸激酶活性的融合蛋白。这种蛋白质刺激粒细胞前体的增殖，并导致CML的发展。这种融合蛋白的激酶活性是蛋白激酶抑制剂伊马替尼的靶标。{{exhibit_1}}\n\n(选项A) 伯基特淋巴瘤的特征是8号染色体长臂上的c-myc癌基因易位到14号染色体上的Ig重链区。这导致c-myc的组成型过度产生，c-myc是一种充当转录激活因子的核磷蛋白。\n\n(选项C) 滤泡性淋巴瘤患者发生t(14;18)易位，导致抗凋亡BCL2基因产物过度表达。\n\n(选项D) Li-Fraumeni综合征是多种癌症的常染色体显性易感性，特别是肉瘤和乳腺、脑和肾上腺皮质的肿瘤。这种综合征与肿瘤抑制基因p53的突变有关。\n\n(选项E) 11号染色体上的cyclin D1基因座与14号染色体上的免疫球蛋白重链基因座之间的易位是套细胞淋巴瘤的特征。这种异常导致cyclin D1的产生增加，cyclin D1是细胞周期中G1到S期转变的促进者。"
  },
  "summary": {
    "en": "This question tests the understanding of molecular pathophysiology of different cancers, specifically focusing on gene translocations and fusion proteins. It requires knowledge of the mechanisms driving tumorigenesis in non-small cell lung cancer and comparing it to other hematologic malignancies and cancer predisposition syndromes.\n\nTo solve this question, identify the key mechanism in the given scenario (EML4-ALK fusion protein) and then match it to the most similar mechanism in the answer choices. Understanding the specific translocations and gene products involved in each cancer type is crucial for selecting the correct answer.",
    "zh": "这个问题测试对不同癌症的分子病理生理学的理解，特别侧重于基因易位和融合蛋白。它需要了解驱动非小细胞肺癌肿瘤发生的机制，并将其与其他血液恶性肿瘤和癌症易感综合征进行比较。\n\n为了解决这个问题，确定给定场景中的关键机制（EML4-ALK融合蛋白），然后将其与答案选项中最相似的机制匹配。了解每种癌症类型中涉及的特定易位和基因产物对于选择正确的答案至关重要。"
  },
  "tags": "Non-small cell lung cancer; EML4-ALK; Chronic myelogenous leukemia; Gene translocation; Fusion protein; Tyrosine kinase; Crizotinib; Imatinib; Burkitt lymphoma; Follicular lymphoma; Li-Fraumeni syndrome; Mantle cell lymphoma",
  "category": "Blood",
  "question_id": "8281",
  "has_exhibits": true,
  "exhibit_count": 1,
  "exhibit_files": [
    "image1.jpg"
  ],
  "folder_path": "C:\\Datas\\usmle\\step1\\clip\\Blood 23\\8281",
  "extracted_at": "2025-11-05T11:34:23.414968",
  "extraction_config": {
    "temperature": 0.1,
    "top_k": 1,
    "prompt_strategy": "standard"
  },
  "translated_at": "2025-11-07T16:32:19.081449",
  "translation_model": "gemini-2.0-flash-lite",
  "embedding_model": "models/embedding-001",
  "embedding_dimension": 768
}